Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolia to prevent bone loss after bariatric surgery
NCT04087096Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2020
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis comparing Denosumab Arm with Placebo Arm (2 arms). Primary endpoint: Percentage Change in Total Hip Bone Mineral Density at 19 months. Started Aug 2020; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04087096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04087096.